Arrowhead Pharmaceuticals Inc logo

Arrowhead Pharmaceuticals Inc

NAS:ARWR (USA)  
$ 19.62 -0.13 (-0.66%) 12:44 PM EST
At Loss
P/B:
13.25
Volume:
331.46K
Avg Vol (2M):
1.59M
Trade In:
Volume:
331.46K
At Loss
Avg Vol (2M):
1.59M

Business Description

Description
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
Name Current Vs Industry Vs History
Cash-To-Debt 1.33
Equity-to-Asset 0.16
Debt-to-Equity 2.75
Debt-to-EBITDA -0.91
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.5
Distress
Grey
Safe
Beneish M-Score -16.62
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 26.72
9-Day RSI 35.45
14-Day RSI 40.99
6-1 Month Momentum % -27.29
12-1 Month Momentum % -38.91

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.74
Quick Ratio 6.74
Cash Ratio 6.6
Days Sales Outstanding 128.18

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6
Shareholder Yield % -5.12

Financials (Next Earnings Date:2025-02-06 Est.)

ARWR's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ARWR

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Arrowhead Pharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 3.551
EPS (TTM) ($) -5.01
Beta 0.9
Volatility % 70.49
14-Day RSI 40.99
14-Day ATR ($) 1.318081
20-Day SMA ($) 22.55375
12-1 Month Momentum % -38.91
52-Week Range ($) 17.05 - 39.83
Shares Outstanding (Mil) 124.43

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Arrowhead Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Arrowhead Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Arrowhead Pharmaceuticals Inc Frequently Asked Questions

What is Arrowhead Pharmaceuticals Inc(ARWR)'s stock price today?
The current price of ARWR is $19.62. The 52 week high of ARWR is $39.83 and 52 week low is $17.05.
When is next earnings date of Arrowhead Pharmaceuticals Inc(ARWR)?
The next earnings date of Arrowhead Pharmaceuticals Inc(ARWR) is 2025-02-06 Est..
Does Arrowhead Pharmaceuticals Inc(ARWR) pay dividends? If so, how much?
Arrowhead Pharmaceuticals Inc(ARWR) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1